Conferences ASH 2019: Immunotherapy superior to chemotherapy for children with relapsed B-ALL December 11, 2019 The immunotherapy drug blinatumomab significantly improved survival in children with relapsed B-acute lymphoblastic leukaemia (B-ALL)…